Greenbrook TMS Announces Dates for Its Second Quarter 2022 Financial Results

Rhea-AI Summary

Greenbrook TMS Inc. (NASDAQ: GBNH) will announce its 2022 second quarter operational and financial results post-market on August 2, 2022. A conference call is scheduled for August 3, 2022, at 10:00 a.m. ET, featuring CEO Bill Leonard and CFO Erns Loubser, to discuss the financial outcomes. Interested parties can join via toll-free numbers or stream the call on their investor relations webpage. Greenbrook operates 193 treatment centers across the U.S. and has provided over 840,000 TMS treatments to more than 24,000 patients with depression.

Positive

• Leading provider of TMS therapy with 193 centers in operation.
• Over 840,000 TMS treatments provided, indicating strong service demand.

Negative

• None.

TORONTO--(BUSINESS WIRE)-- Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), will release its 2022 second quarter operational and financial results after market hours on August 2, 2022.

SECOND QUARTER 2022 CONFERENCE CALL DETAILS:

Bill Leonard, President and Chief Executive Officer, and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 a.m. (Eastern Time) on August 3, 2022 to discuss the financial results for the quarter.

Dial in Numbers:

Toll Free North America: 1 (888) 886 7786
Toronto: (416) 764 8658

Webcast:

For more information or to listen to the call via webcast, please visit:
www.greenbrooktms.com/investors/events.htm

For those that plan on accessing the conference call or webcast, please allow ample time prior to the call time.

Conference Call Replay:

Following the live call, a replay will be available on the Investor Relations section of the Company’s website, www.greenbrooktms.com/investors/events.htm

About Greenbrook TMS Inc.

Operating through 193 Company-operated treatment centers (including those added through the Acquisition), Greenbrook is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 840,000 TMS treatments to over 24,000 patients struggling with depression.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220727006023/en/

Glen Akselrod

Investor Relations

Greenbrook TMS Inc.

Contact Information:

investorrelations@greenbrooktms.com

1-855-797-4867

Source: Greenbrook TMS Inc.

FAQ

What are Greenbrook TMS Inc.'s Q2 2022 financial results release date?

Greenbrook TMS Inc. will release its Q2 2022 financial results on August 2, 2022.

When is the conference call for Greenbrook TMS Inc.'s financial results?

The conference call for Greenbrook TMS Inc.'s financial results is on August 3, 2022, at 10:00 a.m. ET.

How many TMS treatments has Greenbrook TMS Inc. provided?

Greenbrook TMS Inc. has provided over 840,000 TMS treatments to more than 24,000 patients.

What is the focus of Greenbrook TMS Inc.'s therapy?

Greenbrook TMS Inc. specializes in TMS therapy for Major Depressive Disorder and other mental health disorders.